StonvexLoading…
StonvexStonvexStonvexCore line items from LGVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $398.00K | $1.20M | $834.00K | $697.00K |
Operating Income | $-4.78M | $-23.29M | $-17.89M | $-10.58M |
Net Income | $-4.74M | $-22.70M | $-17.26M | $-10.04M |
EPS (Diluted) | $-0.19 | $-1.29 | $-1.07 | $-0.67 |
Total Assets | $21.21M | $10.26M | $15.56M | $16.75M |
Total Liabilities | $5.18M | $4.59M | $5.59M | $4.09M |
Cash & Equivalents | $15.76M | $4.66M | $9.24M | $10.33M |
Free Cash Flow OCF − CapEx | $-4.37M | $-18.89M | $-13.59M | $-8.48M |
Shares Outstanding | 24.79B | 17.58B | 16.12B | 14.98B |